Clinical Trial Update: Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atorvastatin to prevent acute graft-versus-host disease after matched-sibling allogeneic transplantation; results were completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: West Virginia University | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-06-07